Atai Life Sciences Basic EPS 2020-2024 | ATAI

Atai Life Sciences basic eps from 2020 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
Atai Life Sciences Annual Basic EPS
2023 $-0.25
2022 $-0.98
2021 $-1.21
2020 $-1.83
2019 $-0.16
Atai Life Sciences Quarterly Basic EPS
2024-09-30 $-0.16
2024-06-30 $-0.36
2024-03-31 $-0.17
2023-12-31 $-0.11
2023-09-30 $0.28
2023-06-30 $-0.21
2023-03-31 $-0.21
2022-12-31 $-0.28
2022-09-30 $-0.22
2022-06-30 $-0.24
2022-03-31 $-0.24
2021-12-31 $-0.64
2021-09-30 $-0.21
2021-06-30 $-0.37
2021-03-31 $0.01
2020-12-31 $-0.91
2020-09-30 $-0.92
2020-06-30 $-0.18
2020-03-31 $0.18
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.305B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Elanco Animal Health (ELAN) United States $5.492B 13.07
Option Care Health (OPCH) United States $5.459B 25.87
RadNet (RDNT) United States $4.453B 98.62
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
U.S Physical Therapy (USPH) United States $1.298B 34.13
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00